Publications

Found 1 results
Filters: Author is Z.H. Hu  [Clear All Filters]
2011
X. W. Hou, Hu, Z. H., Cui, Y., Gao, W., Sun, S. P., and Wang, N. F., G501C polymorphism of the oxidized LDL receptor gene is associated with albuminuria in Chinese essential hypertension patients, vol. 10, pp. 2710-2717, 2011.
Basi S and Lewis JB (2006). Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J. Kidney Dis. 47: 927-946.http://dx.doi.org/10.1053/j.ajkd.2006.02.182PMid:16731288Biocca S, Falconi M, Filesi I, Baldini F, et al. (2009). Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS One 4: e4648.http://dx.doi.org/10.1371/journal.pone.0004648PMid:19247493    PMCid:2645694Brinkley TE, Kume N, Mitsuoka H, Brown MD, et al. (2008). Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels. Exp. Physiol. 93: 1085-1090.http://dx.doi.org/10.1113/expphysiol.2008.042267PMid:18469066    PMCid:2652129Cerasola G, Mule G, Cottone S, Nardi E, et al. (2008). Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study. J. Nephrol. 21: 368-373.PMid:18587725Cilingiroglu M and Ozer K (2005). The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis. Curr. Atheroscler. Rep. 7: 103-107.http://dx.doi.org/10.1007/s11883-005-0031-3PMid:15727724Cominacini L, Fratta PA, Garbin U, Pastorino A, et al. (2003). The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J. Am. Coll. Cardiol. 41: 499-507.http://dx.doi.org/10.1016/S0735-1097(02)02811-5Gerber LM, Schwartz JE and Pickering TG (2006). Albumin-to-creatinine ratio predicts change in ambulatory blood pressure in normotensive persons: a 7.5-year prospective study. Am. J. Hypertens. 19: 220-226.http://dx.doi.org/10.1016/j.amjhyper.2005.07.025PMid:16448897Hattori H, Sonoda A, Sato H, Ito D, et al. (2006). G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res. 1121: 246-249.http://dx.doi.org/10.1016/j.brainres.2006.08.091PMid:17022953Hou XW, Wang LF, Wang N, Pang D, et al. (2008). The G501C polymorphism of oxidized LDL receptor gene [OLR-1] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives. Clin. Chim. Acta 388: 200-203.http://dx.doi.org/10.1016/j.cca.2007.11.016PMid:18054331Hu C, Kang BY, Megyesi J, Kaushal GP, et al. (2009). Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int. 76: 521-527.http://dx.doi.org/10.1038/ki.2009.234PMid:19553911Klausen KP, Parving HH, Scharling H and Jensen JS (2007). The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J. Intern. Med. 262: 470-478.http://dx.doi.org/10.1111/j.1365-2796.2007.01839.xPMid:17875184Klausen KP, Parving HH, Scharling H and Jensen JS (2009). Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin. Endocrinol. 71: 40-45.http://dx.doi.org/10.1111/j.1365-2265.2008.03427.xPMid:18803675Kurnaz O, Aydogan HY, Isbir CS, Tekeli A, et al. (2009). Is LOX-1 K167N polymorphism protective for coronary artery disease? In Vivo 23: 969-973.PMid:20023241Li L, Roumeliotis N, Sawamura T and Renier G (2004). C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ. Res. 95: 877-883.http://dx.doi.org/10.1161/01.RES.0000147309.54227.42PMid:15472120Mango R, Biocca S, del VF, Clementi F, et al. (2005). In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ. Res. 97: 152-158.http://dx.doi.org/10.1161/01.RES.0000174563.62625.8ePMid:15976314Nagase M, Kaname S, Nagase T, Wang G, et al. (2000). Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J. Am. Soc. Nephrol. 11: 1826-1836.PMid:11004213Ogura S, Kakino A, Sato Y, Fujita Y, et al. (2009). Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ. J. 73: 1993-1999.http://dx.doi.org/10.1253/circj.CJ-09-0587PMid:19801851Ohmori R, Momiyama Y, Nagano M, Taniguchi H, et al. (2004). An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin. Cardiol. 27: 641-644.http://dx.doi.org/10.1002/clc.4960271112PMid:15562935Perticone F, Maio R, Tripepi G, Sciacqua A, et al. (2007). Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J. Nephrol. 20 (Suppl 12): S56-S62.PMid:18050145Perticone F, Maio R, Perticone M, Sciacqua A, et al. (2010). Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation 122: 379-384.http://dx.doi.org/10.1161/CIRCULATIONAHA.110.940932PMid:20625109Schrader J, Luders S, Kulschewski A, Hammersen F, et al. (2006). Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J. Hypertens. 24: 541-548.http://dx.doi.org/10.1097/01.hjh.0000209991.48928.c4PMid:16467658Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, et al. (2003). Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem. Biophys. Res. Commun. 303: 247-250.http://dx.doi.org/10.1016/S0006-291X(03)00326-7Trabetti E, Biscuola M, Cavallari U, Malerba G, et al. (2006). On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur. J. Hum. Genet. 14: 127-130.PMid:16251892Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, et al. (2010). ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study. Am. J. Kidney Dis. 55: 1050-1059.http://dx.doi.org/10.1053/j.ajkd.2009.11.024PMid:20189274Ueno T, Kaname S, Takaichi K, Nagase M, et al. (2003). LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res. 26: 117-122.http://dx.doi.org/10.1291/hypres.26.117PMid:12661921Ueno T, Fukuda N, Tsunemi A, Yao EH, et al. (2009). A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function. J. Hypertens. 27: 508-516.http://dx.doi.org/10.1097/HJH.0b013e3283207fe1PMid:19330905Viazzi F, Leoncini G, Conti N, Tomolillo C, et al. (2010). Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study. Clin. J. Am. Soc. Nephrol. 5: 1099-1106.http://dx.doi.org/10.2215/CJN.07271009PMid:20430941    PMCid:2879305Yamamoto N, Toyoda M, Abe M, Kobayashi T, et al. (2009). Lectin-like oxidized LDL receptor-1 (LOX-1) expression in the tubulointerstitial area likely plays an important role in human diabetic nephropathy. Intern. Med. 48: 189-194.http://dx.doi.org/10.2169/internalmedicine.48.1251PMid:19218767Yuyun MF, Khaw KT, Luben R, Welch A, et al. (2004). Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int. J. Epidemiol. 33: 189-198.http://dx.doi.org/10.1093/ije/dyh008PMid:15075168